Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Hjermann

Showing results (31-40 of 146) with videos related to

Pageof 15
Sort By:
Lancet (London, England)|May 1, 1982
Cholesterol, smoking, and the Oslo StudyI Hjermann, I Holme, P Leren
Acta Medica Scandinavica|December 1, 1970
Prognostic significance of ECG-changes in survivors of myocardial infarction. Five-year follow-up studyP Leren, I Hjermann, J Björnson
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 17, 2001
[Diet and secondary prevention of coronary heart disease--are our recommendations good enough?]L K Johnson, I Hjermann, S Tonstad
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 10, 1979
[Diet and cardiovascular diseases]I Hjermann, C Müller, K R Norum
American Heart Journal|November 1, 1983
The Oslo study: CHD risk factors, socioeconomic influences, and interventionP Leren, A Helgeland, I Hjermann, et al.
Acta Medica Scandinavica. Supplementum|January 1, 1982
Socio-economic status as a coronary risk factor: the Oslo studyI Holme, A Helgeland, I Hjermann, et al.
The American Journal of Medicine|January 1, 1978
Serum triglycerides and serum uric acid in untreated and thiazide-treated patients with mild hypertension. The Oslo studyA Helgeland, I Hjermann, I Holme, et al.
British Medical Journal|April 1, 1978
Possible metabolic side effects of beta-adrenergic blocking drugsA Helgeland, I Hjermann, P Leren, et al.
Acta Medica Scandinavica|April 1, 1970
One year's experience of medical intensive care unitsO Skjaeggestad, H Grendahl, I Hjermann, et al.
Atherosclerosis|April 26, 1996
Exercise-induced increase in lipoprotein (a)I Holme, P Urdal, S Anderssen, et al.
Pageof 15

Showing results (31-40 of 146) with videos related to

Sort By:
Pageof 15
Lancet (London, England)|May 1, 1982
Cholesterol, smoking, and the Oslo StudyI Hjermann, I Holme, P Leren
Acta Medica Scandinavica|December 1, 1970
Prognostic significance of ECG-changes in survivors of myocardial infarction. Five-year follow-up studyP Leren, I Hjermann, J Björnson
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 17, 2001
[Diet and secondary prevention of coronary heart disease--are our recommendations good enough?]L K Johnson, I Hjermann, S Tonstad
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 10, 1979
[Diet and cardiovascular diseases]I Hjermann, C Müller, K R Norum
American Heart Journal|November 1, 1983
The Oslo study: CHD risk factors, socioeconomic influences, and interventionP Leren, A Helgeland, I Hjermann, et al.
Acta Medica Scandinavica. Supplementum|January 1, 1982
Socio-economic status as a coronary risk factor: the Oslo studyI Holme, A Helgeland, I Hjermann, et al.
The American Journal of Medicine|January 1, 1978
Serum triglycerides and serum uric acid in untreated and thiazide-treated patients with mild hypertension. The Oslo studyA Helgeland, I Hjermann, I Holme, et al.
British Medical Journal|April 1, 1978
Possible metabolic side effects of beta-adrenergic blocking drugsA Helgeland, I Hjermann, P Leren, et al.
Acta Medica Scandinavica|April 1, 1970
One year's experience of medical intensive care unitsO Skjaeggestad, H Grendahl, I Hjermann, et al.
Atherosclerosis|April 26, 1996
Exercise-induced increase in lipoprotein (a)I Holme, P Urdal, S Anderssen, et al.
Pageof 15